Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Moderna
MRNA
|
$2.75B |
| 2 |
Coupang
CPNG
|
$1.09B |
| 3 |
Trade Desk
TTD
|
$793M |
| 4 |
BioNTech
BNTX
|
$736M |
| 5 |
Bilibili
BILI
|
$639M |
Top Sells
| 1 |
Tesla
TSLA
|
$7.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$1.39B |
| 3 |
Meta Platforms (Facebook)
META
|
$880M |
| 4 |
Amazon
AMZN
|
$773M |
| 5 |
NIO
NIO
|
$619M |
Sector Composition
| 1 | Consumer Discretionary | 31.93% |
| 2 | Healthcare | 19.13% |
| 3 | Technology | 17.13% |
| 4 | Communication Services | 14.58% |
| 5 | Financials | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Accenture
ACN
$158B
| $13K | ﹤0.01% |
48
+1
| +2% | +$271 |
|
377
Brady Corp
BRC
$3.92B
| $13K | ﹤0.01% |
245
-11
| -4% | -$584 |
|
378
FibroGen
FGEN
$45.7M
| $13K | ﹤0.01% |
15
+1
| +7% | +$867 |
|
379
Fox Class A
FOXA
$27.1B
| $13K | ﹤0.01% |
359
+16
| +5% | +$579 |
|
380
Hormel Foods
HRL
$13.9B
| $13K | ﹤0.01% |
264
+17
| +7% | +$837 |
|
381
Incyte
INCY
$16.7B
| $13K | ﹤0.01% |
165
-19
| -10% | -$1.5K |
|
382
J&J Snack Foods
JJSF
$2.11B
| $13K | ﹤0.01% |
83
+4
| +5% | +$627 |
|
383
Lowe's Companies
LOW
$148B
| $13K | ﹤0.01% |
69
-3
| -4% | -$565 |
|
384
Mativ Holdings
MATV
$659M
| $13K | ﹤0.01% |
265
-5
| -2% | -$245 |
|
|
NVEE
385
DELISTED
NV5 Global
NVEE
| $13K | ﹤0.01% |
552
+40
| +8% | +$942 |
|
386
Ultragenyx Pharmaceutical
RARE
$3.01B
| $13K | ﹤0.01% |
115
+9
| +8% | +$1.02K |
|
387
Stryker
SYK
$151B
| $13K | ﹤0.01% |
54
-1
| -2% | -$241 |
|
388
Texas Roadhouse
TXRH
$11.3B
| $13K | ﹤0.01% |
131
-6
| -4% | -$595 |
|
389
Darden Restaurants
DRI
$24.5B
| $12K | ﹤0.01% |
82
-2
| -2% | -$293 |
|
390
L3Harris
LHX
$51.1B
| $12K | ﹤0.01% |
61
+4
| +7% | +$787 |
|
391
PTC Therapeutics
PTCT
$4.61B
| $12K | ﹤0.01% |
246
| – | – |
|
|
SILK
392
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $12K | ﹤0.01% |
235
+2
| +0.9% | +$102 |
|
393
Jack Henry & Associates
JKHY
$11.8B
| $11K | ﹤0.01% |
71
-2
| -3% | -$310 |
|
394
Liberty Broadband Class C
LBRDK
$8.53B
| $11K | ﹤0.01% |
70
-1
| -1% | -$157 |
|
395
LCI Industries
LCII
$2.56B
| $11K | ﹤0.01% |
86
-3
| -3% | -$384 |
|
396
Paychex
PAYX
$49.4B
| $11K | ﹤0.01% |
116
-1
| -0.9% | -$95 |
|
397
Seer Inc
SEER
$114M
| $11K | ﹤0.01% |
+223
| New | +$11K |
|
398
Tenable Holdings
TENB
$3.68B
| $11K | ﹤0.01% |
315
-13
| -4% | -$454 |
|
|
MDRX
399
DELISTED
Veradigm Inc. Common Stock
MDRX
| $11K | ﹤0.01% |
744
+40
| +6% | +$591 |
|
|
STMP
400
DELISTED
Stamps.com, Inc.
STMP
| $11K | ﹤0.01% |
55
-2
| -4% | -$400 |
|